Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure

Pharmacogenomics Journal

Volumn 10, Issue 1, 2010, Pages 46-53

  Wu, C K ^a   Luo, J L ^b,d   Tsai, C T ^a   Huang, Y T ^c   Cheng, C L ^a   Lee, J K ^a   Lin, L Y ^a   Lin, J W ^a   Hwang, J J ^a   Chiang, F T ^a,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KEELUNG HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Angiotensin converting enzyme inhibitors; Cohort studies; Diastolic; Genetic; Heart failure; Polymorphism

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOSINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHIONINE; NITRATE; RENIN; THREONINE; THYMINE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHARMACOGENETICS; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURVIVAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; HEART FAILURE, DIASTOLIC; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; PROPENSITY SCORE; PROSPECTIVE STUDIES; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 75549089270     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2009.39     Document Type: Article

References (31)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-225.
2. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
3. Zile MR. Heart failure with preserved ejection fraction: is this diastolic heart failure? J Am Coll Cardiol 2003; 41: 1519-1522.
4. Yturralde RF, Gaasch WH. Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 314-319.
5. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-1955.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
7. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2002-2007.
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717.
9. Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol 2008; 101: 639-644.
10. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008; 94: 573-580.
11. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19: 990-1003.
12. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004; 109: 1640-1646.
13. Wu CK, Tsai CT, Hwang JJ, Luo JL, Juang JJ, Hsu KL et al. Renin-angiotensin system gene polymorphisms and diastolic heart failure. Eur J Clin Invest 2008; 38: 789-797.
14. Haviland A, Nagin DS, Rosenbaum PR. Combining propensity score matching and group-based trajectory analysis in an observational study. Psychol Methods 2007; 12: 247-267.
15. Feinstein A. The role of observational studies in the evaluation of therapy. Stat Med 1984; 3: 341-345.
16. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ et al. propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 2007; 28: 1334-1343.
17. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 2008; 372: 554-561.
18. Philbin EF, Rocco Jr TA. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 1997; 134: 188-195.
19. Philbin EF, Rocco Jr TA, Lindenmuth NW, Ulrich K, Jenkins PL. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000; 109: 605-613.
20. Grigorian Shamagian L, Roman AV, Ramos PM, Veloso PR, Bandin Dieguez MA, Gonzalez-Juanatey JR. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study. J Card Fail 2006; 12: 128-133.
21. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-2345.
22. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781.
23. Huang W, Xie C, Zhou H, Yang T, Sun M. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Eur J Heart Fail 2004; 6: 23-27.
24. Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 2004; 25: 2143-2148.
25. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712. (Pubitemid 26289226)
26. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 2003; 34: 1634-1639.
27. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20: 484-492.
28. Wu CK, Tsai CT, Chang YC, Luo JL, Wang YC, Hwang JJ et al. Genetic Polymorphisms of the Angiotensin II type 1 receptor gene and diastolic heart failure. J Hyperten 2009; 27: 502-507.
29. Wu CK, Luo JL, Wu XM, Tsai CT, Lin JW, Hwang JJ et al. A propensity score based case control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. Atherosclerosis 2009; 205: 497-502.
30. Flesch M, Schiffer F, Zolk O, Pinto Y, Stasch JP, Knorr A. et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 1997; 15: 1001-1009.
31. Sanderson JE, Yu CM, Young RP, Shum IO, Wei S, Arumanayagam M et al. Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese. Am Heart J 1999; 137: 653-657.